Unclassified Organic Compounds
Pentatriacontane 95.0+%, TCI America™
CAS: 630-07-9 Molecular Formula: C35H72 Molecular Weight (g/mol): 492.961 MDL Number: MFCD00059397 InChI Key: VHQQPFLOGSTQPC-UHFFFAOYSA-N Synonym: n-pentatriacontane,8ci 9ci,acmc-209nc1,pentatriacontane, analytical standard PubChem CID: 12413 IUPAC Name: pentatriacontane SMILES: CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCC
Chembridge Corporation 2-METHYL-1,3-BENZOXAZOL-6-OL
2-methyl-1,3-benzoxazol-6-ol. 5078-07-9 MFCD00464862
Chembridge Corporation 2-METHYL-1,3-BENZOXAZOL-6-OL
2-methyl-1,3-benzoxazol-6-ol. 5078-07-9 MFCD00464862
Sigma Aldrich Fine Chemicals Biosciences (+)-Butaclamol Hydrochloride | 55528-07-9 | MFCD00082307 | 5mg
(+)-Butaclamol Hydrochloride | Mol Wt: 397.98 | 55528-07-9 | MFCD00082307 | 5mg
Sigma Aldrich Fine Chemicals Biosciences Dehydroleucodine >=98% (HPLC) | 36150-07-9 | MFCD06794926 | 25MG
Dehydroleucodine >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 244.29 | 36150-07-9 | MFCD06794926 | 25MG
Sigma Aldrich Fine Chemicals Biosciences Dehydroleucodine >=98% (HPLC) | 36150-07-9 | MFCD06794926 | 5MG
Dehydroleucodine >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 244.29 | 36150-07-9 | MFCD06794926 | 5MG
Medchemexpress LLC Simufilam hydrochloride | 2480226-07-9 | 99.9% | 295.81 | 50 MG
Simufilam hydrochloride (PTI-125 hydrochloride) is an orally active FLNA modulator. It restores NMDAR signaling and Arc expression, inhibits overactive mTOR signaling, improves insulin sensitivity, and reduces Aβ42-induced neuroinflammation and tau protein hyperphosphorylation, making it suitable for Alzheimer's disease research.
- Restores NMDAR signaling and Arc expression
- Inhibits overactive mTOR signaling
- Improves insulin sensitivity
- Reduces Aβ42-induced neuroinflammation
- Reduces tau protein hyperphosphorylation
- Reduces FLNA-α7nAChR/TLR4 associations
- Restores α7nAChR/NMDAR/IR function
- Enhances spatial/working memory
Medchemexpress LLC Simufilam hydrochloride | 2480226-07-9 | >99.9% | 295.81 | 100 MG
Simufilam hydrochloride is an orally active FLNA modulator. It restores NMDAR signaling and Arc expression, inhibits overactive mTOR signaling by restoring the normal conformation of FLNA, improves insulin sensitivity, and reduces Aβ42-induced neuroinflammation and tau protein hyperphosphorylation. It can be used for research of Alzheimer's disease.
- Restores NMDAR signaling and Arc expression
- Inhibits overactive mTOR signaling by restoring the normal conformation of FLNA
- Improves insulin sensitivity
- Reduces Aβ42-induced neuroinflammation and tau protein hyperphosphorylation
Sigma Aldrich Fine Chemicals Biosciences Asimadoline hydrochloride >=98% (HPLC) | 185951-07-9 | MFCD28987467 | 25MG
Asimadoline hydrochloride >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 451 | 185951-07-9 | MFCD28987467 | 25MG
Sigma Aldrich Fine Chemicals Biosciences Asimadoline hydrochloride >=98% (HPLC) | 185951-07-9 | MFCD28987467 | 5MG
Asimadoline hydrochloride >=98% (HPLC) | Purity: >=98% (HPLC) | Mol Wt: 451 | 185951-07-9 | MFCD28987467 | 5MG
eMolecules 4-Phenyloxan-4-ol | 81462-07-9 | MFCD00729123 | 1g
Combi-Blocks | 4-Phenyloxan-4-ol | 1g | 290703987 | SH-6120 | 95.000 | 81462-07-9 | MFCD00729123 | 178.231 | C11H14O2
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
eMolecules (1S,2S)-(+)-2-Benzyloxycyclohexylamine | 216394-07-9 | MFCD01075753 | 25g
Combi-Blocks | (1S,2S)-(+)-2-Benzyloxycyclohexylamine | 25g | 495744392 | QC-3660 | 96.000 | 216394-07-9 | MFCD01075753 | 205.301 | C13H19NO
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool
Medchemexpress LLC Lysophosphatidylcholine 18:2 | 22252-07-9 | 99.1% | 519.65 | 10 MG
Lysophosphatidylcholine 18:2 is a lysophospholipid and a potential biomarker identified from insulin resistance (IR) polycystic ovary syndrome (PCOS). Low plasma levels of this compound predict impaired glucose tolerance, insulin resistance, type 2 diabetes, coronary artery disease, and memory impairment. This product is for research use only and not sold to patients.
- Lysophospholipid and endogenous metabolite
- Potential biomarker for insulin resistance (IR) polycystic ovary syndrome (PCOS)
- Associated with impaired glucose tolerance, insulin resistance, type 2 diabetes
- Implies inflammation, obesity, and memory impairment
- Contributes to the separation of IR PCOS and control groups
- For research use only
Medchemexpress LLC Lysophosphatidylcholine 18:2 | 22252-07-9 | 99.1% | 519.65 | 5 MG
Lysophosphatidylcholine 18:2 (1-Linoleoyl-2-Hydroxy-sn-glycero-3-PC) is a lysophospholipid identified as a potential biomarker for insulin resistance (IR) polycystic ovary syndrome (PCOS). Low plasma levels of this compound are associated with impaired glucose tolerance, insulin resistance, type 2 diabetes, coronary artery disease, and memory impairment. It is classified as a human endogenous metabolite and is relevant to disease markers, infection, and endocrine diseases.
- Contributes to distinguishing between IR PCOS and control groups
- Associated with inflammation, insulin resistance, obesity, and type 2 diabetes
- A major class of glycerophospholipids in human plasma
eMolecules 1-(a-D-ribofuranosyl)uracil | 3258-07-9 | MFCD17430297 | 1g
Ambeed | 1-(a-D-ribofuranosyl)uracil | 1g | 525012238 | A116627 | | 3258-07-9 | MFCD17430297 | 244.203 | C9H12N2O6
If you are unable to find the chemical you are looking for, make sure you are logged into your fishersci.com account and click on the following link:
eMolecules Building Block Tool